This inventor holds 13 USPTO granted patents, plus 1 CIPO patent and 2 EPO patents. Top assignees: World Force Technologies, LLC, Life Force Technologies, LLC, Topical Remedy, LLC. Active years: 2006-2023.
Company Filing History:
5 out of 5 
4 out of 4 
2 out of 2 Years Active: 2006-2023
Title: Jack Konowalchuk: Innovator in Viral Inhibition and Cancer Research
Introduction
Jack Konowalchuk is a notable inventor based in Newport, Oregon, with a remarkable portfolio of 13 patents. His work primarily focuses on the development of high molecular weight polysaccharides that have significant implications in the fields of virology and oncology.
Latest Patents
Among his latest inventions is a high molecular weight polysaccharide that binds and inhibits viruses. This innovative formulation not only provides methods for inhibiting viral infectivity and pathogenicity but also includes immunogenic compositions. Furthermore, it offers methods for inhibiting the growth of cancer cells and ameliorating symptoms of aging. Additionally, the invention encompasses techniques for detecting, quantifying, and isolating viruses, showcasing its multifaceted applications in medical science.
Career Highlights
Throughout his career, Jack has contributed to various companies, including World Force Technologies, LLC and Life Force Technologies, LLC. His expertise in developing pharmaceutical formulations has positioned him as a key player in the innovation landscape.
Collaborations
Jack has collaborated with notable individuals in his field, including his coworker Thomas W. Konowalchuk. Their joint efforts have further advanced research and development in viral inhibition and cancer treatment.
Conclusion
Jack Konowalchuk's contributions to science and technology through his patents and collaborations highlight his commitment to addressing critical health challenges. His innovative work continues to pave the way for advancements in virology and oncology.